Journal of Chinese Integrative Medicine ›› 2011, Vol. 9 ›› Issue (4): 365-373.doi: 10.3736/jcim20110404
• Study Protocol • Previous Articles Next Articles
Hong-ming Nie, Yue-qiu Gao, Jian-jie Chen(
)
| [1] |
Strader DB, Wright T, Thomas DL, Seeff LB . American Association For the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C[J]. Hepatology, 2004,39(4):1147-1171
doi: 10.1002/hep.20119 |
| [2] | Epidemiology and natural history. In: Schinazi RF, Sommadossi JP, Thomas HC. Therapies for viral hepatitis[M]. London: International Medical Press, 1998 |
| [3] | Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitology of Chinese Medical Association. Prevention and treatment program for hepatitis C in China[J]. Zhonghua Gang Zang Bing Za Zhi, 2004,12(4):194-198 |
| 中华医学会肝病学分会,中华医学会传染病与寄生虫病学分会. 丙型肝炎防治指南[J]. 中华肝脏病杂志, 2004,12(4):194-198 | |
| [4] |
Lindsay KL . Introduction to therapy of hepatitis C[J]. Hepatology, 2002,36(5 Suppl 1):S114-S120
doi: 10.1002/hep.1840360715 pmid: 1240758412 |
| [5] |
Seeff LB, Hoofnagle JH . National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002[J]. Hepatology, 2002,36(5 Suppl 1):S3-S20
doi: 10.1310/hct.2003.4.1.008 pmid: 12407571 |
| [6] |
McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS; IDEAL Study Team . Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection[J]. N Engl J Med, 2009,361(6):580-593
doi: 10.1056/NEJMoa0808010 pmid: 19625712 |
| [7] |
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J . Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J]. N Engl J Med, 2002,347(13):975-982
doi: 10.1056/NEJMoa020047 pmid: 12324553 |
| [8] | Chen JJ, Wang LT, Ren JJ, Gao YQ, Le M, Zhuo YH . Clinical study on chronic hepatits C treated with Qinggan Granules[J]. Zhong Xi Yi Jie He Gan Bing Za Zhi, 2001,11(4):195-197 |
| 陈建杰, 王灵台, 任进余, 高月求, 乐敏, 卓蕴慧 . 清肝冲剂对慢性丙型肝炎的作用研究[J]. 中西医结合肝病杂志, 2001,11(4):195-197 | |
| [9] | Chen JJ, Wang LT, Ren JJ, Gao YQ, Zhuo YH, Le M . Clinical study on chronic hepatitis C treated with Kidney-Tonifying Granule[J]. Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi, 2001,9(6):334-336 |
| 陈建杰, 王灵台, 任进余, 高月求, 卓蕴慧, 乐敏 . 补肾冲剂治疗慢性丙型肝炎的临床研究[J]. 中国中西医结合消化杂志, 2001,9(6):334-336 | |
| [10] | Li Y, Chen JJ . Study of HCV genetype distribution to 71 patients with chronic hepatitis C in Shanghai district[J]. Zhong Xi Yi Jie He Gan Bing Za Zhi, 2006,16(6):360-362 |
| 李莹, 陈建杰 . 上海地区71例慢性丙型病毒性肝炎患者基因型分布研究[J]. 中西医结合肝病杂志, 2006,16(6):360-362 | |
| [11] |
Li YP, Huang ZJ, Zhang H, Chen C . Feasibility of the MOS 36-item Short Form Health Survey in the assessment of the quality of life in hepatitis B patients[J]. Zhongguo Yu Fang Yi Xue Za Zhi, 2007,8(4):352-355
doi: 10.3969/j.issn.1009-6639.2007.04.007 |
|
李跃平, 黄子杰, 张宏, 陈聪 . SF-36量表在乙型肝炎患者生存质量测量中的可行性评价[J]. 中国预防医学杂志, 2007,8(4):352-355
doi: 10.3969/j.issn.1009-6639.2007.04.007 |
|
| [12] |
Wu CH, Deng QW, Ji XS, Yan LM . Preliminary use of the CLDQ in chronic hepatitis B patients[J]. Zhongguo Lin Chuang Xin Li Xue Za Zhi, 2003,11(1):60-62
doi: 10.3969/j.issn.1005-3611.2003.01.020 |
|
吴创鸿, 邓启文, 纪晓抒, 阎郎明 . 慢性肝病问卷在慢性乙型肝炎患者中的试用[J]. 中国临床心理学杂志, 2003,11(1):60-62
doi: 10.3969/j.issn.1005-3611.2003.01.020 |
|